The inflammatory cytokines interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) were reported to induce Nurr1 expression, which, in the presence of TGF-β, potentiates SMAD activation of cancer development [76]. The gene discussed is TGFB1; the disease is cancer.